65674 Federal Register / Vol. 83, No. 245 / Friday, December 21, 2018 / Notices 

FEDERAL RESERVE SYSTEM 

Change in Bank Control Notices; 

Acquisitions of Shares of a Bank or 

Bank Holding Company 

The notificants listed below have 

applied under the Change in Bank 

Control Act (12 U.S.C. 1817(j)) and 

§ 225.41 of the Board’s Regulation Y (12 

CFR 225.41) to acquire shares of a bank 

or bank holding company. The factors 

that are considered in acting on the 

notices are set forth in paragraph 7 of 

the Act (12 U.S.C. 1817(j)(7)). 

The notices are available for 

immediate inspection at the Federal 

Reserve Bank indicated. The notices 

also will be available for inspection at 

the offices of the Board of Governors. 

Interested persons may express their 

views in writing to the Reserve Bank 

indicated for that notice or to the offices 

of the Board of Governors. Comments 

must be received not later than January 

8, 2019. 

A. Federal Reserve Bank of Chicago 

(Colette A. Fried, Assistant Vice 

President) 230 South LaSalle Street, 

Chicago, Illinois 60690–1414: 

1. Gary F. Stewart and Carrie L. Irish, 

as a group acting in concert to be added 

to the Hodgson family control group 

approved on October 10, 2013; to retain 

voting shares of Charlevoix First 

Corporation and thereby indirectly 

retain shares of Charlevoix State Bank, 

both of Charlevoix, Michigan. 

B. Federal Reserve Bank of Kansas 

City (Dennis Denney, Assistant Vice 

President) 1 Memorial Drive, Kansas 

City, Missouri 64198–0001: 

1. The Lisa K. Haines Financial 

Services Trust and the Julee S. 

Thummel Financial Services Trust, both 

of Horseshoe Bay, Texas; to retain 

voting shares of Bank7 Corp and thereby 

indirectly retain shares of Bank 7, both 

of Oklahoma City, Oklahoma. 

Board of Governors of the Federal Reserve 

System, December 18, 2018. 

Yao-Chin Chao, 

Assistant Secretary of the Board. 

[FR Doc. 2018–27667 Filed 12–20–18; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Board of Scientific Counselors, 

National Center for Health Statistics 

(BSC, NCHS) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

Centers for Disease Control and 

Prevention (CDC), announces the 

following meeting for the Board of 

Scientific Counselors, National Center 

for Health Statistics (BSC, NCHS). This 

meeting is open to the public. 

DATES: The meeting will be held on 

January 22, 2019, 11:00 a.m. to 2:00 

p.m., EDT. 

ADDRESSES: Virtual—Summaries of 

meetings and a roster of Committee 

members are available on the NCHS 

BSC website: https://www.cdc.gov/nchs/ 

about/bsc.htm. 

FOR FURTHER INFORMATION CONTACT: 

Sayeedha Uddin, M.D., M.P.H., 

Executive Secretary, NCHS/CDC, Board 

of Scientific Counselors, 3311 Toledo 

Road, Room 2627, Hyattsville, Maryland 

20782, telephone (301) 458–4303, email 

isx9@cdc.gov. 

SUPPLEMENTARY INFORMATION: To join 

the session go to https://roseliassociates.

webex.com/roseliassociates/k2/j.php?

MTID=tfdddad42079860e7fedf3935962

fd22f. 

2. Enter your name and email address 

(or registration ID). 

3. Enter the session password: Jan22. 

4. Click ‘‘Join Now’’. 

5. Follow the instructions that appear 

on your screen. 

To join the session by phone only call 

the number below and enter the access 

code. 

United States Toll Free: 1–844–621– 

3956. 

United States Toll (San Jose): +1–240– 

454–0887. 

Global call-in numbers: https://

roseliassociates.webex.com/ 

roseliassociates/globalcallin.

php?serviceType=TC&ED=753000

972&tollFree=1. 

Show toll-free dialing restrictions: 

https://www.webex.com/pdf/tollfree_

restrictions.pdf. 

Access code: 647 874 925. 

For assistance you can contact 

Michele Dillon at: michele.dillon@

roseliassociates.com, 1–301–412–0987. 

Can’t join the training session? 

https://collaborationhelp.cisco.com/ 

article/qg8vzfb. 

To update this session to your 

calendar program (for example 

Microsoft Outlook), click this link: 

https://roseliassociates.webex.com/ 

roseliassociates/k2/j.php?

MTID=t1946c9546eabdef918f44

ebc6b656537. 

https://www.webex.com. 

Purpose: This committee is charged 

with providing advice and making 

recommendations to the Secretary, 

Department of Health and Human 

Services; the Director, CDC; and the 

Director, NCHS, regarding the scientific 

and technical program goals and 

objectives, strategies, and priorities of 

NCHS. 

Matters to be considered: The agenda 

will include remarks by NCHS 

leadership; presentation and discussion 

of the Patient-Centered Outcomes 

Research Trust Fund Drug Workgroup 

report. Agenda items are subject to 

change as priorities dictate. The Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Sherri Berger, 

Chief Operating Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. 2018–27719 Filed 12–20–18; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Board of Scientific Counselors, 

National Center for Health Statistics 

(BSC, NCHS); Correction 

Notice is hereby given of a change in 

the meeting of the Board of Scientific 

Counselors, National Center for Health 

Statistics (BSC, NCHS); December 4, 

2018, 11:00 a.m.–5:30 p.m., EDT, and 

December 5, 2018, 8:30 a.m.–1:00 p.m., 

EDT which was published in the 

Federal Register on November 16, 2017 

Volume 82, Number 220, pages 53500– 

53501. 

The date should read as follows: 

December 4, 2018 10:00 a.m.–5:00 p.m. 

EST. 

The MATTERS TO BE CONSIDERED 

should read as follows: The meeting 

agenda includes welcome remarks by 

NCHS leadership; an update on the 

National Health Interview Statistics 

Redesign Bridge Sample; an update on 

the Utilization of Electronic Health 

Records (EHR) Data in NCHS Data 

Systems update on National Study of 

Long-Term Care Providers; an update 

from the Patient-Centered Outcomes 

Research Trust Fund Drug Workgroup; 

an update on Indicator Selection for 

Healthy People 2030; and an update on 

Evaluation of Birth Outcomes 

Associated with Drug Use. 


amozie on DSK3GDR082PROD with NOTICES1
Federal Register / Vol. 83, No. 245 / Friday, December 21, 2018 / Notices 65675 

FOR FURTHER INFORMATION CONTACT: 

Sayeedha Uddin, M.D., M.P.H., 

Executive Secretary, NCHS/CDC, Board 

of Scientific Counselors, 3311 Toledo 

Road, Room 2627, Hyattsville, Maryland 

20782, telephone (301) 458–4303, email 

isx9@cdc.gov. 

The Chief Operating Officer, Centers 

for Disease Control and Prevention, has 

been delegated the authority to sign 

Federal Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Sherri Berger 

Chief Operating Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. 2018–27718 Filed 12–20–18; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

CDC/HRSA Advisory Committee on 

HIV, Viral Hepatitis and STD Prevention 

and Treatment (CHACHSPT); Notice of 

Charter Renewal 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of charter renewal. 

SUMMARY: This gives notice under the 

Federal Advisory Committee Act of 

October 6, 1972, that the CDC/HRSA 

Advisory Committee on HIV, Viral 

Hepatitis and STD Prevention and 

Treatment (CHACHSPT), Centers for 

Disease Control and Prevention, 

Department of Health and Human 

Services, has been renewed for a 2-year 

period through November 25, 2020. 

FOR FURTHER INFORMATION CONTACT: 

Jonathan Mermin, M.D., M.P.H., 

Designated Federal Officer, CDC/HRSA 

Advisory Committee on HIV, Viral 

Hepatitis and STD Prevention and 

Treatment (CHACHSPT), CDC, HHS, 

1600 Clifton Road, NE, Mailstop E07, 

Atlanta, Georgia 30329–4027, 

Telephone 404–639–8000, jhm7@

cdc.gov. 

The Chief Operating Officer, Centers 

for Disease Control and Prevention, has 

been delegated the authority to sign 

Federal Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Sherri Berger, 

Chief Operating Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. 2018–27717 Filed 12–20–18; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting. 

The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c) (4) and (6), Title 

5 U.S.C., and the Determination of the 

Director, Management Analysis and 

Services Office, CDC, pursuant to Public 

Law 92–463. 

Name of Committee: Safety and 

Occupational Health Study Section (SOHSS); 

National Institute for Occupational Safety 

and Health (NIOSH). 

Date: February 20–21, 2019. 

Time: 8:00 a.m.–5:00 p.m., EST. 

Place: Embassy Suites, 1900 Diagonal 

Road, Alexandria, VA 22314. 

Agenda: The meeting will convene to 

address matters related to the conduct of 

Study Section business and for the study 

section to consider safety and occupational 

health-related grant applications. 

For Further Information Contact: Nina 

Turner, Ph.D., Scienitific Review Officer, 

NIOSH, 1095 Willowdale Road, Morgantown, 

WV 26506, (304) 285–5976; nturner@cdc.gov. 

The Chief Operating Officer, Centers for 

Disease Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for both 

the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Sherri Berger, 

Chief Operating Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. 2018–27721 Filed 12–20–18; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended, and the Determination of 

the Director, Management Analysis and 

Services Office, CDC, pursuant to Public 

Law 92–463. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Disease, Disability, 

and Injury Prevention and Control Special 

Emphasis Panel (SEP)—PAR 13–129; NIOSH 

Member Conflict Special Emphasis Panel. 

Date: February 26, 2019. 

Time: 12:00 p.m.–4:00 p.m. EST. 

Place: Teleconference. 

Agenda: To review and evaluate grant 

applications. 

For Further Information Contact: Nina 

Turner, Ph.D., Scientific Review Officer, 

Office of Extramural Programs, 1095 

Willowdale Road, Morgantown, West 

Virginia 26506, Telephone: (304) 285–5976; 

Email: nxt2@cdc.gov. 

The Chief Operating Officer, Centers for 

Disease Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for both 

the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Sherri Berger, 

Chief Operating Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. 2018–27722 Filed 12–20–18; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

CDC/Mine Safety and Health Research 

Advisory Committee (MSHRAC); 

Notice of Charter Renewal 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 


amozie on DSK3GDR082PROD with NOTICES1